litlas
ログインアカウント作成

Evan J. Lipson

2011–2025 年に発表

91
論文数
22,755
被引用数
55
h 指数
87
i10 指数

被引用数

Evan J. Lipson の年別被引用数1997 年: 被引用 5 件2009 年: 被引用 1 件2010 年: 被引用 1 件2011 年: 被引用 1 件2012 年: 被引用 9 件2013 年: 被引用 31 件2014 年: 被引用 145 件2015 年: 被引用 344 件2016 年: 被引用 417 件2017 年: 被引用 553 件2018 年: 被引用 431 件2019 年: 被引用 1,181 件2020 年: 被引用 1,318 件2021 年: 被引用 1,102 件2022 年: 被引用 1,081 件2023 年: 被引用 846 件2024 年: 被引用 1,365 件2025 年: 被引用 701 件2026 年: 被引用 24 件1998〜2008 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,716 件、この内訳の 28.4%中国: 引用元論文 1,529 件、この内訳の 11.7%イタリア: 引用元論文 746 件、この内訳の 5.7%ドイツ: 引用元論文 722 件、この内訳の 5.5%イギリス: 引用元論文 666 件、この内訳の 5.1%フランス: 引用元論文 577 件、この内訳の 4.4%オーストラリア: 引用元論文 482 件、この内訳の 3.7%スペイン: 引用元論文 409 件、この内訳の 3.1%オランダ: 引用元論文 373 件、この内訳の 2.8%日本: 引用元論文 364 件、この内訳の 2.8%カナダ: 引用元論文 354 件、この内訳の 2.7%スイス: 引用元論文 316 件、この内訳の 2.4%
0%28.4%その他 21.7%

機関

分野

  • Medicine64%
  • Biochemistry, Genetics and Molecular Biology26.6%
  • Immunology and Microbiology5.7%
  • Engineering1.2%
  • Computer Science0.5%
  • Mathematics0.5%
  • その他1.5%

トピック

  • Cancer Immunotherapy and Biomarkers15.2%
  • Cancer Genomics and Diagnostics8.2%
  • CAR-T cell therapy research5.2%
  • Immunotherapy and Immune Responses5.1%
  • Lung Cancer Treatments and Mutations3%
  • Immune Cell Function and Interaction3%
  • その他60.3%

共著者

全論文

検索で開く
  1. Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma

    著者: Hussein A. Tawbi, Dirk Schadendorf, Evan J. Lipson, Paolo A. Ascierto, Luis Matamala, Erika Castillo Gutiérrez, Piotr Rutkowski, Helen J. Gogas, Christopher D. Lao, Juliana Janoski De Menezes, Stéphane Dalle, Ana Arance, Jean-Jacques Grob, Shivani Srivastava, Mena Abaskharoun, Melissa Hamilton, Sarah Keidel, Katy L. Simonsen, Anne Marie Sobiesk, Bin Li, F. Stephen Hodi, Georgina V. Long - New England Journal of Medicine 2022 被引用: 1,759

  2. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

    著者: Chetan Bettegowda, Mark Sausen, Rebecca Leary, Isaac Kinde, Yuxuan Wang, Nishant Agrawal, Bjarne R. Bartlett, Hao Wang, Brandon Luber, Rhoda M. Alani, Emmanuel S. Antonarakis, Nilofer S. Azad, Alberto Bardelli, Henry Brem, John L. Cameron, Clarence Lee, Leslie A. Fecher, Gary L. Gallia, Peter Gibbs, Dung T. Le, Robert Giuntoli, Michael Goggins, Michael D. Hogarty, Matthias Holdhoff, Seung‐Mo Hong, Yuchen Jiao, Hartmut Juhl, Jaeyeon Kim, Giulia Siravegna, Daniel A. Laheru, Calogero Lauricella, Michael Lim, Evan J. Lipson, Suely Kazue Nagahashi Marie, George J. Netto, Kelly S. Oliner, Alessandro Olivi, Louise Olsson, Gregory J. Riggins, Andrea Sartore‐Bianchi, Kerstin Schmidt, le-Ming Shih, Sueli Mieko Oba‐Shinjo, Salvatore Siena, Dan Theodorescu, Jeanne Tie, Timothy T. Harkins, Silvio Veronese, Tian‐Li Wang, Jon Weingart, Christopher L. Wolfgang, Laura D. Wood, Dongmei Xing, Ralph H. Hruban, Jian Wu, Peter J. Allen, C. Max Schmidt, Michael A. Choti, Victor E. Velculescu, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Luis A. Díaz - Science Translational Medicine 2014 被引用: 5,110

  3. Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

    著者: Suzanne L. Topalian, Mario Sznol, David F. McDermott, Harriet M. Kluger, Richard D. Carvajal, William H. Sharfman, Julie R. Brahmer, Donald P. Lawrence, Michael B. Atkins, John D. Powderly, Philip D. Leming, Evan J. Lipson, Igor Puzanov, David C. Smith, Janis M. Taube, Jon M. Wigginton, Georgia Kollia, Ashok Gupta, Drew M. Pardoll, Jeffrey A. Sosman, F. Stephen Hodi - Journal of Clinical Oncology 2014 被引用: 2,207

  4. Cardiovascular toxicities associated with immune checkpoint inhibitors

    著者: Jiun‐Ruey Hu, Roberta Florido, Evan J. Lipson, Jarushka Naidoo, Reza Ardehali, Carlo G. Tocchetti, Alexander R. Lyon, Robert F. Padera, Douglas B. Johnson, Javid J. Moslehi - Cardiovascular Research 2019 被引用: 506

  5. Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

    著者: Neil D. Gross, David M. Miller, Nikhil I. Khushalani, Vasu Divi, Emily S. Ruiz, Evan J. Lipson, Friedegund Meier, Yungpo B. Su, Paul Swiecicki, Jennifer Atlas, J.L. Geiger, Axel Hauschild, Jennifer H. Choe, Brett Hughes, Dirk Schadendorf, Vishal Patel, Jade Homsi, Janis M. Taube, Annette M. Lim, Renata Ferrarotto, Howard L. Kaufman, Frank Seebach, Israel Lowy, Suk‐Young Yoo, Melissa Mathias, Keilah Fenech, Hyunsil Han, Matthew G. Fury, Danny Rischin - New England Journal of Medicine 2022 被引用: 309

  6. PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma

    著者: Paul Nghiem, Shailender Bhatia, Evan J. Lipson, Ragini R. Kudchadkar, Natalie Miller, Lakshmanan Annamalai, Sneha Berry, Elliot Chartash, Adil Daud, Steven P. Fling, Philip Friedlander, Harriet M. Kluger, Holbrook E. Kohrt, Lisa Lundgren, Kim Margolin, Alan Mitchell, Thomas Olencki, Drew M. Pardoll, Sunil Reddy, Erica Shantha, William H. Sharfman, Elad Sharon, Lynn Shemanski, Michi M. Shinohara, Joel Sunshine, Janis M. Taube, John A. Thompson, Steven M. Townson, Jennifer H. Yearley, Suzanne L. Topalian, Martin A. Cheever - New England Journal of Medicine 2016 被引用: 1,243

  7. Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial

    著者: Paolo A. Ascierto, Evan J. Lipson, Reinhard Dummer, James Larkin, Georgina V. Long, Rachel E. Sanborn, Vanna Chiarion‐Sileni, Brigitte Dréno, Stéphane Dalle, Dirk Schadendorf, Margaret K. Callahan, Marta Nyakas, Victoria Atkinson, Carlos Gomez‐Roca, Naoya Yamazaki, Hussein A. Tawbi, Naomey Sarkis, Deepti Warad, Sonia Dolfi, Priyam Mitra, Satyendra Suryawanshi, Jean‐Jacques Grob - Journal of Clinical Oncology 2023 被引用: 155

  8. Overall Survival and Response with Nivolumab and Relatlimab in Advanced Melanoma

    著者: Georgina V. Long, F. Stephen Hodi, Evan J. Lipson, Dirk Schadendorf, Paolo A. Ascierto, Luis Matamala, Pamela Salman, Erika Castillo Gutiérrez, Piotr Rutkowski, Helen Gogas, Christopher D. Lao, J. Menezes, Stéphane Dalle, Ana Arance, Jean‐Jacques Grob, Sarah Keidel, Anadil Shaikh, Anne Marie Sobiesk, Sonia Dolfi, Hussein A. Tawbi - NEJM Evidence 2023 被引用: 124

  9. Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma

    著者: Evan J. Lipson, Charles G. Drake - Clinical Cancer Research 2011 被引用: 564

  10. Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade

    著者: Sneha Berry, Nicolás A. Giraldo, Benjamin Green, Tricia R. Cottrell, Julie E. Stein, Elizabeth L. Engle, Haiying Xu, Aleksandra Ogurtsova, Charles A. Roberts, Daphne Wang, Peter Nguyen, Qingfeng Zhu, Sigfredo Soto-Diaz, Jose Loyola, Inbal Sander, Pok Fai Wong, Shlomit Jessel, Joshua Doyle, Danielle Signer, Richard Wilton, J. Roskes, Margaret Eminizer, Seyoun Park, Joel Sunshine, Elizabeth M. Jaffee, Alexander S. Baras, Angelo M. De Marzo, Suzanne L. Topalian, Harriet M. Kluger, Leslie Cope, Evan J. Lipson, Ludmila Danilova, Robert A. Anders, David L. Rimm, Drew M. Pardoll, Alexander S. Szalay, Janis M. Taube - Science 2021 被引用: 204

  11. Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy

    著者: Lucie Heinzerling, Patrick A. Ott, F. Stephen Hodi, Aliya N. Husain, Azadeh Tajmir-Riahi, Hussein A. Tawbi, Matthias Pauschinger, Thomas F. Gajewski, Evan J. Lipson, Jason J. Luke - Journal for ImmunoTherapy of Cancer 2016 被引用: 514

  12. The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis

    著者: Karthik Suresh, Jarushka Naidoo, Qiong Zhong, Ye Xiong, Jennifer S. Mammen, Marcia Villegas de Flores, Laura C. Cappelli, Aanika Balaji, Tsvi Palmer, Patrick M. Forde, Valsamo Anagnostou, David S. Ettinger, Kristen A. Marrone, Ronan J. Kelly, Christine L. Hann, Benjamin Levy, Josephine Feliciano, Cheng Ting Lin, David Feller‐Kopman, Andrew D. Lerner, Hans C. Lee, Mājid Shafiq, Lonny Yarmus, Evan J. Lipson, Mark J. Soloski, Julie R. Brahmer, Sonye K. Danoff, Franco R. D’Alessio - Journal of Clinical Investigation 2019 被引用: 198

  13. Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade

    著者: Julie E. Stein, Evan J. Lipson, Tricia R. Cottrell, Patrick M. Forde, Robert A. Anders, Ashley Cimino‐Mathews, Elizabeth D. Thompson, Mohamad E. Allaf, Mark Yarchoan, Josephine Feliciano, Hao Wang, Elizabeth M. Jaffee, Drew M. Pardoll, Suzanne L. Topalian, Janis M. Taube - Clinical Cancer Research 2019 被引用: 180

  14. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors

    著者: Frank B. Cortazar, Kristen A. Marrone, Megan L. Troxell, Kenneth M. Ralto, Melanie P. Hoenig, Julie R. Brahmer, Dung T. Le, Evan J. Lipson, Ilya Glezerman, Jedd D. Wolchok, Lynn D. Cornell, P. A. Feldman, Michael B. Stokes, Sarah A. Zapata, F. Stephen Hodi, Patrick A. Ott, M Yamashita, David E. Leaf - Kidney International 2016 被引用: 643

  15. Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy

    著者: Paul Nghiem, Shailender Bhatia, Evan J. Lipson, William H. Sharfman, Ragini R. Kudchadkar, Andrew S. Brohl, Phillip Friedlander, Adil Daud, Harriet M. Kluger, Sunil Reddy, Brian C. Boulmay, Adam I. Riker, Melissa Burgess, Brent A. Hanks, Thomas Olencki, Kim Margolin, Lisa Lundgren, Abha Soni, Nirasha Ramchurren, Candice D. Church, Song Y. Park, Michi M. Shinohara, Bob Salim, Janis M. Taube, Steven Bird, Nageatte Ibrahim, Steven P. Fling, Blanca Homet Moreno, Elad Sharon, Martin A. Cheever, Suzanne L. Topalian - Journal of Clinical Oncology 2019 被引用: 390

  16. Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation

    著者: Tawnie Braaten, Julie R. Brahmer, Patrick M. Forde, Dung T. Le, Evan J. Lipson, Jarushka Naidoo, Megan D. Schollenberger, Lei Zheng, Clifton O. Bingham, Ami A. Shah, Laura C. Cappelli - Annals of the Rheumatic Diseases 2019 被引用: 227

  17. Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

    著者: Paul Nghiem, Shailender Bhatia, Evan J. Lipson, William H. Sharfman, Ragini R. Kudchadkar, Andrew S. Brohl, Philip Friedlander, Adil Daud, Harriet M. Kluger, Sunil Reddy, Brian C. Boulmay, Adam I. Riker, Melissa Burgess, Brent A. Hanks, Thomas Olencki, Kari Kendra, Candice D. Church, Tomoko Akaike, Nirasha Ramchurren, Michi M. Shinohara, Bob Salim, Janis M. Taube, Erin Jensen, Mizuho Kalabis, Steven P. Fling, Blanca Homet Moreno, Elad Sharon, Martin A. Cheever, Suzanne L. Topalian - Journal for ImmunoTherapy of Cancer 2021 被引用: 140

  18. Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding

    著者: Lawrence P. Andrews, Ashwin Somasundaram, Jessica Moskovitz, Andrea L. Szymczak-Workman, Chang Liu, Anthony R. Cillo, Lin Huang, Daniel P. Normolle, Kelly D. Moynihan, Ichiro Taniuchi, Darrell J. Irvine, John M. Kirkwood, Evan J. Lipson, Robert L. Ferris, Tullia C. Bruno, Creg J. Workman, Dario A.A. Vignali - Science Immunology 2020 被引用: 85

  19. Evolutionary dynamics of cancer in response to targeted combination therapy

    著者: Ivana Božić, Johannes G. Reiter, Benjamin Allen, Tibor Antal, Krishnendu Chatterjee, Preya Shah, Yo Sup Moon, Amin Yaqubie, Nicole Kelly, Dung T. Le, Evan J. Lipson, Paul B. Chapman, Luis A. Díaz, Bert Vogelstein, Martin A. Nowak - eLife 2013 被引用: 647

  20. Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity

    著者: Chang Liu, Ashwin Somasundaram, Sasikanth Manne, Angela M. Gocher, Andrea L. Szymczak-Workman, Kate M. Vignali, Ellen Scott, Daniel P. Normolle, E. John Wherry, Evan J. Lipson, Robert L. Ferris, Tullia C. Bruno, Creg J. Workman, Dario A.A. Vignali - Nature Immunology 2020 被引用: 151

  21. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

    著者: Linda Chen, Jacqueline Douglass, Lawrence Kleinberg, Xiaobu Ye, Ariel E. Marciscano, Patrick M. Forde, Julie R. Brahmer, Evan J. Lipson, William H. Sharfman, Hans J. Hammers, Jarushka Naidoo, Chetan Bettegowda, Michael Lim, Kristin J. Redmond - International Journal of Radiation Oncology*Biology*Physics 2017 被引用: 327

  22. Neoadjuvant cemiplimab and surgery for stage II–IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study

    著者: Neil D. Gross, David M. Miller, Nikhil I. Khushalani, Vasu Divi, Emily S. Ruiz, Evan J. Lipson, Friedegund Meier, Yungpo Bernard Su, Paul Swiecicki, Jennifer Atlas, J.L. Geiger, Axel Hauschild, Jennifer H. Choe, Brett Hughes, Dirk Schadendorf, Vishal Patel, Jade Homsi, Janis M. Taube, Annette M. Lim, Renata Ferrarotto, Suk‐Young Yoo, Melissa Mathias, Hyunsil Han, Frank Seebach, Israel Lowy, Matthew G. Fury, Danny Rischin - The Lancet Oncology 2023 被引用: 100

  23. Melanoma subtypes demonstrate distinct PD-L1 expression profiles

    著者: Genevieve J. Kaunitz, Tricia R. Cottrell, Mohammed Lilo, Valliammai Muthappan, Jessica Esandrio, Sneha Berry, Haiying Xu, Aleksandra Ogurtsova, Robert A. Anders, Alexander H. Fischer, Stefan Kraft, Meg R. Gerstenblith, Cheryl L. Thompson, Kord Honda, Jonathan D. Cuda, Charles G. Eberhart, James T. Handa, Evan J. Lipson, Janis M. Taube - Laboratory Investigation 2017 被引用: 207

  24. Chronic immune checkpoint inhibitor pneumonitis

    著者: Jarushka Naidoo, Tricia R. Cottrell, Evan J. Lipson, Patrick M. Forde, Peter B. Illei, Lonny Yarmus, Khinh Ranh Voong, David Feller‐Kopman, Hans C. Lee, Joanne Riemer, Daphne Wang, Janis M. Taube, Julie R. Brahmer, Cheng Ting Lin, Sonye K. Danoff, Franco R. D’Alessio, Karthik Suresh - Journal for ImmunoTherapy of Cancer 2020 被引用: 96